Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / China

AstraZeneca Looking To Expand In China

March 2007 | Company Finance Alert

UK-based drugmaker AstraZeneca is expecting sales in China to grow by around 20% annually between 2006-2010. In the same period, BMI estimates that the CAGR for the total Chinese pharmaceutical market will be 14.7%.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
Novartis Follows Pfizer In Shutting Down Local Sites

Industry / United Kingdom The UK: An Attractive Location In Which To Sell Medicines
March 2011
Explicit Price Cuts Unlikely

Industry / United Kingdom BMI Core View: Governments will increasingly impose price controls on pharmaceuticals. Drugmakers have generally charged what the market will bear in both developed and emerging markets. High prices were...
March 2011
OTC Sector To Provide Revenue Earning Opportunities

Industry / United Kingdom BMI View: The UK's over-the-counter (OTC) medicines market is one of the most developed both in Europe and the world and is a pioneer in terms of switching drug status from prescription to OTC. It is also...
March 2011
Prescription Drug Charge To Rise

Industry / United Kingdom BMI View: While the sum of GBP450mn (US$728mn) - the income earned by the government as a result of the prescription charge in England - is relatively small when compared with its overall expenditure on...
March 2011
Western Drugmakers Increasingly Looking Towards The East

Industry / China BMI View: The introduction of government price erosion mechanisms will accelerate across Europe, a view that is driven by need for fiscal austerity and supported by the actions of numerous governments...
November 2010
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS